The data debate: management, retention and authentication of product data in the context of the EU falsified medicines directiveAuthor:
Domino Printing Sciences
Whitepaper (.PDF file)
In the third of a series of features created to help pharmaceutical manufacturers prepare for the impending implementation of the EU Falsified Medicines Directive (FMD), Craig Stobie, head - global Life Sciences team at Domino Printing Sciences examines the thinking behind how and why the vast amounts of data acquired under the FMD will be collected, stored and interrogated. This white paper takes a look at the role of those supervising bodies involved in the generation of data, those responsible for its management and how manufacturers can prepare the ground for positive data management.
To download this FREE whitepaper, please complete the form below:
(all fields required)